Bionano Genomics BNGOW 深 沪
等待开盘 09-23 09:30:00 美东时间
0.0036
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0036
- 总市值 100.37万
- 52周最高 0.604
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0019
- 委 比 0.00%
- 总股本 2.79亿
- 历史最高 11.82
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0019
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why BioNano Genomics (BNGO) Stock Is Getting Hammered Tuesday
BioNano Genomics shares are trading sharply lower in Tuesday's session. The company announced the pricing of a $10 million public offering.
09-17 00:53
Bionano Genomics Prices $10M Public Offering Of 5M Shares And Series Warrants At A Combined Price Of $2.00; Could Potentially Earn $20M From Warrant Exercises
Bionano Genomics, Inc. (NASDAQ:BNGO) ("Bionano" or the "Company") today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the Company's common stock (or common stock equivalents in lieu
09-16 21:12
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Check-Cap (NASDAQ:CHEK) shares rose 225.1% to $2.42 during Monday's re...
09-16 01:06
Bionano Genomics Selected For Sole Source Contract By NIH For Optical Genome Mapping Reagents And Instruments; No Contract Value Disclosed
https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.This
09-02 23:43
HC Wainwright & Co. Maintains Buy on Bionano Genomics, Raises Price Target to $11
HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from $10 to $11.
08-18 19:27
Bionano Genomics Q2 EPS $(1.99) Beats $(2.42) Estimate, Sales $6.733M Miss $6.832M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.42) by 17.6 percent. This is a 86.18 percent increase over losses of $(14.40) per share from
08-15 04:34
Bionano Genomics Sees Q3 Sales $6.700M-$7.200M vs $7.661M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.
08-15 04:04
A Preview Of Bionano Genomics's Earnings
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings rep...
08-14 02:02
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target
Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.
05-20 22:39
Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est
Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.
05-15 05:22
